Advice
Following a full submission:
levonorgestrel (Kyleena®) is accepted for use within NHS Scotland.
Indication under review: contraception for up to 5 years.
A phase III, open-label, randomised study confirmed the contraceptive efficacy of levonorgestrel 19.5mg intrauterine delivery system according to the Pearl Index.
Download detailed advice222KB (PDF)
Medicine details
- Medicine name:
- levonorgestrel (Kyleena)
- SMC ID:
- 1299/18
- Indication:
- Contraception for up to 5 years.
- Pharmaceutical company
- Bayer Plc
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Full
- Status
- Accepted
- Date advice published:
- 12 February 2018